A Phase IV, Comparative, Randomized, Double Blind, Single-Dose, 2-Way Crossover Study to Evaluate the Pharmacokinetics and Safety of Alpharma Branded Products Division (KADIAN)and Ligand Pharmaceuticals Inc. (Avinza) 30 mg Morphine Sulfate Sustained-Release Capsules in Healthy Adult Volunteers Under Fed Conditions.
Phase of Trial: Phase IV
Latest Information Update: 21 Jan 2010
At a glance
- Drugs Morphine (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Alpharma
- 23 Nov 2008 New trial record.